• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Krystal Begins Ph 1/2 Trial of KB801 for Neurotrophic Keratitis

    GLOBENEWSWIRE

    Krystal Bio Updates On Gene Therapy For Rare Respiratory Diseases

    GLOBENEWSWIRE

    An eye-drop version of Krystal Biotech`s skin gene therapy helped restore vision of boy with rare disease

    ENDPTS

    Krystal Receives Orphan Drug Designation from the Japanese MHLW for B-VEC

    GLOBENEWSWIRE

    Krystal Biotech Announces Orphan Drug Designation Granted to KB408

    GLOBENEWSWIRE

    Krystal gets EC’s orphan drug designation for KB407 to treat cystic fibrosis

    PHARMABIZ

    Krystal Biotech Receives European Commission Orphan Designation for KB407

    GLOBENEWSWIRE

    Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB105

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.